Get started
Author

Erin E. O’Leary

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery
2016 · Michael D. Dake, Gary M. Ansel, et al. · Circulation · 524
PDF
Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions
2013 · Michael D. Dake, Gary M. Ansel, et al. · Journal of the American College of Cardiology · 329
The Roles of Cbl-b and c-Cbl in Insulin-stimulated Glucose Transport
2003 · Jun Liu, Stephanie M. DeYoung, et al. · Journal of Biological Chemistry · 87
PDF
T-Cell Factor 4N (TCF-4N), a Novel Isoform of Mouse TCF-4, Synergizes with β-Catenin To Coactivate C/EBPα and Steroidogenic Factor 1 Transcription Factors
2003 · Jennifer A. Kennell, Erin E. O'Leary, et al. · Molecular and Cellular Biology · 75
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
2016 · Hiroyoshi Yokoi, Takao Ohki, et al. · JACC: Cardiovascular Interventions · 72
PDF
Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
2019 · Michael D. Dake, Gary M. Ansel, et al. · CardioVascular and Interventional Radiology · 65
PDF
Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
2018 · Kimihiko Kichikawa, Shigeo Ichihashi, et al. · CardioVascular and Interventional Radiology · 29
PDF
Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials
2014 · Takao Ohki, Hiroyoshi Yokoi, et al. · Journal of Endovascular Therapy · 20
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study
2017 · Stefano Cipollari, Hiroyoshi Yokoi, et al. · Journal of Vascular and Interventional Radiology · 17
Identification of Steroid-Sensitive Gene-1/Ccdc80 as a JAK2-Binding Protein
2013 · Erin E. O'Leary, Anna M. Mazurkiewicz-Muñoz, et al. · Molecular Endocrinology · 17
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
2020 · Michael D. Dake, Fabrizio Fanelli, et al. · CardioVascular and Interventional Radiology · 16
PDF
Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study
2020 · Masayuki Sugimoto, Kimihiro Komori, et al. · Journal of Endovascular Therapy · 14
Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan
2017 · Yukihisa Ogawa, Hiroyoshi Yokoi, et al. · CardioVascular and Interventional Radiology · 14
PDF
First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study
2022 · Wei Ye, Tanja Böhme, et al. · Frontiers in Cardiovascular Medicine · 1
PDF
Reply to Dong et al.
2019 · Daisy Walter, Maarten W. van den Berg, et al. · Endoscopy
PDF
Tu1607 A Randomized Comparison of Degradable Esophageal Stent Versus Dilation Therapy for Patients With Recurrent Benign Esophageal Strictures: 6-Month Results (Destiny Study)
2015 · Daisy Walter, Maarten W. Van Den Berg, et al. · Gastrointestinal Endoscopy
Identification of Steroid-Sensitive Gene-1 as a Novel JAK2 Binding Protein and the Physiological Consequences of this Interaction.
2008 · Erin E. O’Leary · Deep Blue (University of Michigan)
PDF
Works count: 17
Citation count: 1,280
H-index: 13
I10-index: 13
Year
Topic
Type